PBH logo

PBH

Profile

Full Name

Prestige Consumer Healthcare Inc.

Ticker Symbol

PBH

Exchange

NYSE

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

IPO

February 10, 2005

Indexes

Not included

Website

http://www.prestigebrands.com

Employees

570

Key Details

Price

$82.12(+1.75%)

Market cap

$4.07B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.13B(-0.21% YoY)

Annual EPS

$4.17(+352.73% YoY)

PE ratio

19.23

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$82.12
PBH price is $82.12

30-Day Relative Volume

0.87
PBH 30-day relative volume is 0.87

Price Performance

Price Most recent change

+1.75%
PBH price was up +1.75% on Apr 11, 2025

Price YTD change

+5.16%
PBH price is up +5.16% since January 1st

Price 1-year change

+18.69%
PBH price is up +18.69% year-on-year

Price 3-year change

+54.39%
PBH price is up +54.39% over the past 3 years

Price Range

Price All-time high

$90.04
PBH price is currently -8.80% below its historical high of $90.04

Price 3-year low

$48.51
PBH price is currently +69.28% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$4.07B
PBH market capitalization is $4.07 billion

Market cap 3-year change

+52.11%
PBH market capitalization is up +52.11% over the past 3 years

Market cap All-time high

$4.42B
PBH market capitalization is currently -7.97% below its historical high of $4.42 billion

Market cap sector rank

88.41%
PBH market capitalization is higher than 88.41% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-0.57%
PBH shares outstanding is down -0.57% year-on-year

Shares Outstanding 3-Year Change

-1.47%
PBH shares outstanding is down -1.47% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.44
PBH beta is 0.44

200-day SMA

$76.88
PBH price is currently +6.81% above its 200-day simple moving average

50-day SMA

$84.13
PBH price is currently -2.38% below its 50-day simple moving average

RSI

45.48
PBH 14-day relative strength index is 45.48

Volume

0.87
PBH 30-day relative volume is 0.87

ATR

$2.79
PBH average true range is $2.79

10-day Historical Volatility

34.96%
PBH 10-day historical volatility is 34.96%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.13B
PBH annual revenue is $1.13 billion

Revenue Analysts estimate

$1.13B
PBH annual revenue is currently -0.47% lower than the consensus analysts' forecast

Revenue 1-year change

-0.21%
PBH annual revenue is down -0.21% year-on-year

Revenue Sector rank

81.08%
PBH annual revenue is higher than 81.08% of companies in Healthcare sector

EPS

EPS

$4.17
PBH annual earnings per share is $4.17

EPS Analysts estimate

$4.50
PBH annual earnings per share is currently -7.44% lower than the consensus analysts' forecast

EPS 1-year change

+352.73%
PBH annual earnings per share is up +352.73% year-on-year

EPS Sector rank

94.8%
PBH annual earnings per share is higher than 94.8% of companies in Healthcare sector

Profit

Gross profit

$624.45M
PBH annual gross profit is $624.45 million

Gross margin

55.49%
PBH annual gross profit margin is 55.49%

Operating profit

$342.43M
PBH annual operating income is $342.43 million

Operating margin

30.43%
PBH annual operating profit margin is 30.43%

Net income

$209.34M
PBH annual net profit is $209.34 million

Net margin

18.60%
PBH annual net profit margin is 18.60%

Expenses

Total expenses

$782.93M
PBH annual total expenses is $782.93 million

Operating expenses

$282.02M
PBH annual total operating expenses is $282.02 million

Cost of goods sold

$500.91M
PBH annual cost of goods sold is $500.91 million

Selling, general & administrative expenses

$259.47M
PBH annual SGA is $259.47 million

Depreciation and amortization

$30.68M
PBH annual depreciation & amortization is $30.68 million

Interest expense

$67.16M
PBH annual interest expense is $67.16 million

Income tax

$66.69M
PBH annual income tax is $66.69 million

EBIT & EBITDA

EBIT

$343.19M
PBH annual earnings before interest & taxes is $343.19 million

EBITDA

$373.86M
PBH annual EBITDA is $373.86 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$3.32B
PBH annual total assets is $3.32 billion

Non current assets

$2.94B
PBH annual long term assets is $2.94 billion

Current assets

$375.04M
PBH annual total current assets is $375.04 million

Cash and cash equivalents

$46.47M
PBH annual cash & cash equivalents is $46.47 million

Accounts receivable

$185.03M
PBH annual accounts receivable is $185.03 million

Inventory

$138.72M
PBH annual inventory is $138.72 million

Liabilities

Total liabilities

$1.66B
PBH annual total liabilities is $1.66 billion

Long term liabilities

$1.55B
PBH annual total long term liabilities is $1.55 billion

Current liabilities

$117.05M
PBH annual total current liabilities is $117.05 million

Accounts payable

$38.98M
PBH annual accounts payable is $38.98 million

Debt

Total debt

$1.14B
PBH annual total debt is $1.14 billion

Total debt 1-year change

-16.64%
PBH annual total debt is down -16.64% year-on-year

Long term debt

$1.13B
PBH annual long term debt is $1.13 billion

Short term debt

$6.15M
PBH annual short term debt is $6.15 million

Equity & Capital

Shareholders equity

$1.66B
PBH annual stockholders equity is $1.66 billion

Book value

$1.66B
PBH annual book value is $1.66 billion

Retained earnings

$1.34B
PBH annual retained earnings is $1.34 billion

Working capital

$258.00M
PBH annual working capital is $258.00 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$248.93M
PBH annual cash flow from operations is $248.93 million

Cash from operations 1-year change

+8.36%
PBH annual cash flow from operations is up +8.36% year-on-year

Cash from investing

-$20.11M
PBH annual cash flow from investing activities is -$20.11 million

Cash from investing 1-year change

-73.61%
PBH annual cash flow from investing activities is down -73.61% year-on-year

Cash from financing

-$241.01M
PBH annual cash flow from financing activities is -$241.01 million

Cash from financing 1-year change

-29.69%
PBH annual cash flow from financing activities is down -29.69% year-on-year

CAPEX

CAPEX

$9.55M
PBH annual capital expenditures is $9.55 million

CAPEX 1-year change

+22.69%
PBH annual capital expenditures is up +22.69% year-on-year

Free Cash Flow

Free cash flow

$239.38M
PBH annual free cash flow is $239.38 million

Free cash flow 1-year change

+7.86%
PBH annual free cash flow is up +7.86% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

55.49%
PBH annual gross profit margin is 55.49%

Operating margin

30.43%
PBH annual operating profit margin is 30.43%

Net margin

18.60%
PBH annual net profit margin is 18.60%

ROA & ROE

ROA

6.28%
PBH annual return on assets is 6.28%

ROE

13.50%
PBH annual return on equity is 13.50%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

19.23
PBH price to earnings ratio is 19.23

PE ratio Sector rank

37.25%
PBH price to earnings ratio is higher than 37.25% of companies in Healthcare sector

PB Ratio

PB ratio

2.27
PBH price to book ratio is 2.27

PB ratio Sector rank

66.61%
PBH price to book ratio is higher than 66.61% of companies in Healthcare sector

PS Ratio

PS ratio

3.64
PBH price to sales ratio is 3.64

PS ratio Sector rank

58.85%
PBH price to sales ratio is higher than 58.85% of companies in Healthcare sector

Enterprise value

Enterprise value

$5.04B
PBH enterprise value is $5.04 billion

Enterprise value Sector rank

88.29%
PBH enterprise value is higher than 88.29% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

13.99
PBH EV/EBITDA is 13.99

EV/EBITDA Sector rank

86.98%
PBH EV/EBITDA is higher than 86.98% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.20
PBH annual current ratio is 3.20

Quick ratio

2.02
PBH annual quick ratio is 2.02

Leverage

Debt to equity

0.68
PBH annual debt to equity ratio is 0.68

Interest coverage ratio

5.11
PBH annual interest coverage ratio is 5.11

Risk & Stability

Piotroski F-Score

7
PBH piotroski f-score is 7

Altman Z-Score

2.81
PBH altman z-score is 2.81

Analyst ratings

Recent major analysts updates

Mar 21, 25 RBC Capital
Sector Perform
Feb 13, 25 Oppenheimer
Outperform
Feb 7, 25 DA Davidson
Buy
Feb 7, 25 Canaccord Genuity
Buy
Nov 11, 24 DA Davidson
Buy
Aug 28, 24 DA Davidson
Buy
Aug 9, 24 DA Davidson
Buy
Aug 9, 24 Canaccord Genuity
Buy
Jun 21, 24 DA Davidson
Buy
May 21, 24 Canaccord Genuity
Buy

Institutional Ownership

Similar stocks

BLCO logo
Bausch Lomb (BLCO)
PCVX logo
Vaxcyte (PCVX)
RDNT logo
RadNet (RDNT)
ITGR logo
Integer Holdings (ITGR)
ELAN logo
Elanco Animal Health Incorporated (ELAN)
ALHC logo
Alignment Healthcare (ALHC)
RYTM logo
Rhythm Pharmaceuticals (RYTM)
INSP logo
Inspire Medical Systems (INSP)
ALKS logo
Alkermes (ALKS)
  • What is the ticker symbol for Prestige Consumer Healthcare?
  • Does Prestige Consumer Healthcare pay dividends?
  • What sector is Prestige Consumer Healthcare in?
  • What industry is Prestige Consumer Healthcare in?
  • What country is Prestige Consumer Healthcare based in?
  • When did Prestige Consumer Healthcare go public?
  • Is Prestige Consumer Healthcare in the S&P 500?
  • Is Prestige Consumer Healthcare in the NASDAQ 100?
  • Is Prestige Consumer Healthcare in the Dow Jones?
  • When was Prestige Consumer Healthcare's last earnings report?
  • When does Prestige Consumer Healthcare report earnings?
  • Should I buy Prestige Consumer Healthcare stock now?

What is the ticker symbol for Prestige Consumer Healthcare?

The ticker symbol for Prestige Consumer Healthcare is NYSE:PBH

Does Prestige Consumer Healthcare pay dividends?

No, Prestige Consumer Healthcare does not pay dividends

What sector is Prestige Consumer Healthcare in?

Prestige Consumer Healthcare is in the Healthcare sector

What industry is Prestige Consumer Healthcare in?

Prestige Consumer Healthcare is in the Drug Manufacturers - Specialty & Generic industry

What country is Prestige Consumer Healthcare based in?

Prestige Consumer Healthcare is headquartered in United States

When did Prestige Consumer Healthcare go public?

Prestige Consumer Healthcare's initial public offering (IPO) was on February 10, 2005

Is Prestige Consumer Healthcare in the S&P 500?

No, Prestige Consumer Healthcare is not included in the S&P 500 index

Is Prestige Consumer Healthcare in the NASDAQ 100?

No, Prestige Consumer Healthcare is not included in the NASDAQ 100 index

Is Prestige Consumer Healthcare in the Dow Jones?

No, Prestige Consumer Healthcare is not included in the Dow Jones index

When was Prestige Consumer Healthcare's last earnings report?

Prestige Consumer Healthcare's most recent earnings report was on Feb 6, 2025

When does Prestige Consumer Healthcare report earnings?

The next expected earnings date for Prestige Consumer Healthcare is May 14, 2025

Should I buy Prestige Consumer Healthcare stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page